The Procter & Gamble Company (NYSE:PG) Stake Lessened by Bath Savings Trust Co

Bath Savings Trust Co cut its position in shares of The Procter & Gamble Company (NYSE:PG) by 1.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 42,974 shares of the company’s stock after selling 611 shares during the quarter. Bath Savings Trust Co’s holdings in Procter & Gamble were worth $7,205,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble during the second quarter valued at $29,000. RPg Family Wealth Advisory LLC bought a new stake in shares of Procter & Gamble in the 3rd quarter valued at approximately $33,000. Quest Partners LLC bought a new stake in Procter & Gamble in the second quarter worth approximately $36,000. Finally, Fairfield Financial Advisors LTD acquired a new position in Procter & Gamble during the second quarter worth $44,000. 65.77% of the stock is currently owned by institutional investors.

Insider Activity

In other Procter & Gamble news, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the transaction, the chief executive officer now owns 13,783 shares in the company, valued at approximately $2,343,110. This trade represents a 12.63 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 75,439 shares of company stock worth $13,317,460. Insiders own 0.18% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on PG shares. Wells Fargo & Company lowered their price target on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating on the stock in a report on Tuesday. JPMorgan Chase & Co. raised their target price on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a report on Thursday, September 19th. Piper Sandler started coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target for the company. Morgan Stanley raised their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Finally, Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Procter & Gamble presently has a consensus rating of “Moderate Buy” and an average price target of $179.75.

Procter & Gamble Price Performance

PG stock traded up $0.70 during trading on Tuesday, hitting $161.30. The company had a trading volume of 4,063,602 shares, compared to its average volume of 5,820,512. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company has a fifty day moving average price of $170.03 and a two-hundred day moving average price of $169.80. The Procter & Gamble Company has a fifty-two week low of $146.28 and a fifty-two week high of $180.43. The company has a market cap of $379.87 billion, a P/E ratio of 27.81, a P/E/G ratio of 3.70 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the prior year, the firm earned $1.83 EPS. The firm’s quarterly revenue was down .6% compared to the same quarter last year. Equities research analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.